The first new antibiotic for UTIs in nearly 30 years has been approved by regulators. Gepotidacin, also known as Blujepa, is ...

UTIs are caused by bacteria like E. coli. But some infections are resistant to antibiotics. (Science Photo Library via Getty Images) Mo Carrier has dealt with recurrent urinary tract infections, ...

Antibiotics do not cause urinary tract infections (UTIs). However, research suggests there may be a link between prior use of antibiotics and a person developing an antibiotic-resistant UTI. A UTI may ...

This guide deconstructs the pathophysiology of UTIs, exploring the anatomical risks in women, and the efficacy of antibiotic ...

Antibiotic Prophylaxis Cuts Recurrent UTI Risk by 50% Cephalexin and ciprofloxacin are suitable alternatives to sulfamethoxazole-trimethoprim as UTI prophylaxis following kidney transplantation.

Bacteria cause urinary tract infections (UTIs), so antibiotics are the first-line treatment. Even when symptoms disappear, a person should finish their antibiotic course according to their doctor’s ...

Pivmecillinam has been used for decades in Europe and may work for UTIs that don’t respond to other antibiotics. Urinary tract infections are one of the most common reasons for antibiotic use.

Respiratory and sinus infections, along with strep throat, and urinary tract infections are some of the most common reasons for antibiotic use worldwide. Urinary tract infections are caused by ...

The first new type of antibiotic developed in more than 20 years to treat urinary tract infections (UTIs) appears to be so effective that the pharmaceutical company stopped testing and will soon ...

About half of women and more than one in 10 men will get a urinary tract infection (UTI) in their lifetime, with many people experiencing recurrent UTIs. These common bacterial infections, which can ...

If approved, the drug will be the first new treatment for uncomplicated urinary tract infections in more than 2 decades. GSK has stopped two phase 3 clinical trials for gepotidacin, a potential new ...